Participation in U.S.‐Based <scp>ALS</scp> Clinical Trials by Sex and Race
U.S.-based ALS trials significantly under-enroll non-White participants, and there are trends toward slight underrepresentation of women. Efforts to broaden trial enrollment amongst people with ALS will help with the generalizability of trial results and hasten trial completion.
Authors
- Sun Young Chung (ORCID: https://orcid.org/0000-0002-3381-919X)
- Mark N. Levine (ORCID: https://orcid.org/0000-0003-1288-0773)
- Sabrina Paganoni (ORCID: https://orcid.org/0000-0003-0505-1168)
- Suma Babu (ORCID: https://orcid.org/0000-0002-2648-7625)
- James D. Berry (ORCID: https://orcid.org/0000-0003-0898-6081)
- Kellen H. Quigg (ORCID: https://orcid.org/0000-0003-4365-2298)
- Judith Carey
Institutions
- NewYork–Presbyterian Hospital (US)
- Emory University (US)
- Cornell University (US)
- University of Michigan (US)
- Massachusetts General Hospital (US)
- Presbyterian Hospital (US)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1002/mus.70050
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health